Related Experiment Video
Updated: Mar 4, 2026
04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
558
Endoscopic Transoral Approach for Resection of Skull Base Rhabdomyosarcoma
Jinfei Su1, Qinzhan Ren, Junqi Liu
1Department of Otorhinolaryngology Head and Neck Surgery, Skull Base Surgery Center, Xuanwu Hospital, Capital Medical University, Beijing, China.
The Journal of Craniofacial Surgery
|March 3, 2026
Summary
This study presents a pediatric case of rhabdomyosarcoma (RMS), a childhood cancer. The tumor, located both outside and inside the skull, was successfully removed using a minimally invasive endoscopic transoral approach (ETA).
Area of Science:
- Pediatric oncology
- Surgical oncology
- Neurosurgery
Background:
- Rhabdomyosarcoma (RMS) is a prevalent childhood malignant tumor.
- Standard treatments include surgery, chemotherapy, and radiotherapy, with surgery being paramount.
- Extracranial and intracranial RMS presents unique surgical challenges.
Purpose of the Study:
- To report a pediatric case of extracranial and intracranial RMS.
- To demonstrate the feasibility of a pure endoscopic transoral approach (ETA) for resection.
- To highlight a novel surgical technique for complex pediatric tumors.
Main Methods:
- A pediatric patient with confirmed extracranial and intracranial RMS was selected.
- Surgical resection was performed using a pure endoscopic transoral approach (ETA).
- Post-operative outcomes and follow-up were documented.
Main Results:
- Complete surgical resection of the extracranial and intracranial RMS was achieved via ETA.
- The endoscopic transoral approach provided excellent visualization and access.
- The patient tolerated the procedure well with no immediate complications.
Conclusions:
- The endoscopic transoral approach (ETA) is a viable and effective surgical option for pediatric extracranial and intracranial rhabdomyosarcoma.
- Minimally invasive techniques like ETA can offer significant advantages in treating complex pediatric tumors.
- Further research into ETA for pediatric RMS is warranted.
